"Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study"
作者："Qin, SK; Chan, SL; Gu, SZ; Bai, YX; Ren, ZG; Lin, XY; Chen, ZD; Jia, WD; Jin, YD; Guo, YB; Hu, XH; Meng, ZQ; Liang, J; Cheng, Y; Xiong, JP; Ren, H; Yang, F; Li, W; Chen, YJ; Zeng, Y; Sultanbaev, A; Pazgan-Simon, M; Pisetska, M; Melisi, D; Ponomarenko, D; Osypchuk, Y; Sinielnikov, I; Yang, TS; Liang, X; Chen, CX; Wang, LN; Cheng, AL; Kaseb, A; Vogel, A"
通讯作者："Qin, SK (通讯作者)，Nanjing Univ Chinese Med, Jinling Hosp, Canc Ctr, Nanjing 210002, Peoples R China.; Qin, SK (通讯作者)，Nanjing Med Univ, Nanjing 210002, Peoples R China."
来源出版物：LANCET  卷：402  页：14  出版年：2023
文献类型：Article  影响因子：98.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
Carbopol dispersed PAA-modified UIO-66 with high colloidal stability as a combination nano-adjuvant boosts immune response and protection against pseudorabies virus in mice and pigs
作者："Liao, XL; Nie, JJ; Yuan, XY; Feng, Z; Cui, E; Wu, Y; Li, Y; Scherman, D; Liu, YS"
通讯作者："Liu, YS (通讯作者)，Southwest Univ, Sch Mat & Energy, Key Lab Luminescence Anal & Mol Sensing, Minist Educ, Chongqing 400715, Peoples R China.; Wu, Y (通讯作者)，Sinopharm Anim Hlth Co Ltd, Adjuvant Res Lab, Wuhan 430073, Peoples R China.; Li, Y (通讯作者)，Chongqing Med Univ, Cent Lab, Yongchuan Hosp, Chongqing 402160, Peoples R China."
来源出版物：ACTA BIOMATERIALIA  卷：168  页：11  出版年：2023
文献类型：Article  影响因子：9.4  JCR分区：Q1  ESI学科分类：MATERIALS SCIENCE
Role of green finance and regional environmental efficiency in China
作者："Zhang, ZW; Fu, H; Xie, SQ; Cifuentes-Faura, J; Urinov, B"
通讯作者："Fu, H (通讯作者)，Chongqing Acad Governance, Chongqing Econ & Social Dev Res Inst, Chongqing, Peoples R China.; Xie, SQ (通讯作者)，Chongqing Med Univ, Nursing Coll, Chongqing, Peoples R China."
来源出版物：RENEWABLE ENERGY  卷：214  页：9  出版年：2023
文献类型：Article  影响因子：9  JCR分区：Q1  ESI学科分类：ENGINEERING
Radioactive immuno-imaging and radioimmunotherapy of 131I-labeled human single- chain variable fragment antibodies against anaplastic thyroid cancer in tumor-bearing nude mice
作者："Liu, Q; Pang, H"
通讯作者：
来源出版物：EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING  卷：50  页：1  出版年：2023
文献类型：Meeting Abstract  影响因子：8.6  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
Hypothalamic FSTL1 modulates energy homeostasis and glucose/lipid metabolism via the Akt-/Foxo1-AgRP pathway
作者："Dai, H; Yang, M; Li, L; Yang, G"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：1  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
Hypothalamic GPC4 and its N-glycosylation regulate feeding and energy metabolism through IR/AKT/FoxO1 signalling pathway
作者："Xia, X; Li, L; Yang, G"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：2  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
NOD1 deficiency ameliorates the progression of diabetic retinopathy via modulating bone marrow-retina crosstalk
作者："Duan, Y; Wu, J; Chen, W; Liu, D"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：1  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
Lactic acid functionalised AuCePt porous hollow nanozyme targeted to alleviate hepatic insulin resistance
作者："Fu, Y; Li, L; Yang, M"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：2  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
Azgp1 signalling in POMC neurons confers protection against diet-induced obesity and hepatic steatosis
作者："Qiu, S; Yang, G; Yang, M; Li, L"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：2  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
CILP2 deficiency ameliorates diabetes related myocardial injury by regulating inflammation and autophagy via AMPK pathway
作者："Hu, L; Li, K"
通讯作者：
来源出版物：DIABETOLOGIA  卷：66  页：1  出版年：2023
文献类型：Meeting Abstract  影响因子：8.4  JCR分区：Q1  ESI学科分类：CLINICAL MEDICINE
共35页 <<  < 1 2 3 4 5 6 7 8 9 10 >  >>